BRANFORD, Conn., December 18, 2024–(BUSINESS WIRE)–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that the Compensation Committee of Quantum-Si’s Board of Directors has granted 46,666 restricted stock units (“RSUs”) to new employees under the Company’s previously adopted Quantum-Si Incorporated 2023 Inducement Equity Incentive Plan, as amended (the “2023 Inducement Plan”). The RSUs were granted as an inducement material to the new employees becoming an employee of Quantum-Si in accordance with Nasdaq Listing Rule 5635(c)(4). The 2023 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously…
Author: user
In a turbulent market environment, Salarius Pharmaceuticals, Inc. (SLRX) stock has recorded a new 52-week low, dipping to $1.24. The micro-cap company, with a market value of just $1.82 million, has been navigating through a challenging phase. While maintaining a healthy current ratio of 4.09 and more cash than debt on its balance sheet, the company has seen its stock price significantly retreat from its 52-week high of $7.20. Investors have been cautious, reflecting in the stock’s performance with a stark 1-year change, showing a decline of -74.29%. This downturn highlights the volatility and the tough conditions faced by the…
In many ways, gauging the impact of the Federal Reserve lowering interest rates is like predicting when ice will thaw. We know something’s happening, but it takes a while, and there’s not much to look at. The Fed has cut short-term interest rates twice this fall, including a jumbo half-point discount to kick off the lower-rate season in September. Market watchers widely expect another quarter-point cut when the Fed meets Dec. 18. So what results can we see? When it comes to your money — checking and savings accounts, CDs, mortgages, and other loans — it often takes fractions to…
Skarie20 / Getty Images/iStockphoto Commitment to Our Readers GOBankingRates’ editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services – our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology. 20 YearsHelping You Live Richer Trusted by Millions of Readers One of the fastest ways to grow your money is to make sure it is doing the earning for you, and not the other way around. If you don’t want to take higher risks with…
A man who has inherited a $550,000 IRA from his father looks over the account paperwork. SmartAsset and Yahoo Finance LLC may earn commission or revenue through links in the content below. If you inherit a tax-deferred retirement account, like an IRA or a 401(k), you’ll pay income taxes on the money when you withdraw it. Those withdrawals are subject to your marginal tax rate, not the original owners. This can reduce the value of your inheritance, potentially by quite a lot if you are in a high tax bracket. For example, say that you’re in the 32% tax bracket…
In a year marked by significant volatility, Teleflex Incorporated (NYSE:) stock has recorded a new 52-week low, dipping to $176.59. According to InvestingPro data, the company maintains a market capitalization of $8.2 billion and currently trades at a P/E ratio of 35.1x. This latest price level reflects a stark contrast to the company’s performance over the past year, with Teleflex witnessing a substantial 1-year change of -30.24%. Investors are closely monitoring the medical device company as it navigates through a challenging market environment, which has seen its stock price erode steadily from previous highs. Despite current challenges, InvestingPro analysis suggests…
Taiwan’s semiconductor industry sits at the crossroads of global technology and geopolitics. As the world becomes increasingly reliant on advanced chips for everything from smartphones to artificial intelligence, Taiwan Semiconductor Manufacturing Company Limited (TSM) has emerged as the critical node in this ecosystem. However, recent geopolitical tensions surrounding Taiwan, combined with rising global demand, have spotlighted TSMC’s delicate yet dominant position in the technology supply chain. As nations prioritize supply chain resilience, TSMC’s role becomes ever more significant—both as a technological leader and a symbol of geopolitical strategy often referred to as Taiwan’s “Silicon Shield.” TSMC’s Unmatched Market Position TSMC…
Danimer Scientific Inc. (NYSE:) stock has reached a 52-week low, dipping to $3.62, as the company faces a tumultuous market environment. According to InvestingPro data, the stock’s RSI indicates oversold territory, while the company’s financial health score remains weak at 1.17 out of 5. This latest price point marks a significant downturn for the biodegradable plastics company over the past year. Investors have witnessed a stark decrease in value, with a total return of -91.21% over the past year. The decline to this 52-week low underscores the challenges DNMR has encountered, including market volatility and investor concerns, which have heavily…
Main Street Capital Corporation (NYSE:) has reached an impressive milestone, with its stock price soaring to an all-time high of $55.87. This peak reflects a significant growth trajectory for the company, marking a substantial 39.93% increase in its stock value over the past year. The company maintains a healthy P/E ratio of 10.08 and offers an attractive dividend yield of 7.01%. According to InvestingPro, MAIN has maintained dividend payments for 18 consecutive years. Investors have shown increased confidence in Main Street Capital’s performance and prospects, contributing to the company’s robust upward momentum in the market. The achievement of this all-time…
On Wednesday, Truist Securities updated their analysis on shares of Boston Scientific (NYSE:BSX), raising the price target to $110 from the previous $100 while keeping a Buy rating on the stock. The adjustment reflects the firm’s confidence in the company’s performance and growth prospects. The medical device giant, currently valued at $133 billion, has demonstrated strong momentum with revenue growth of 15.66% in the latest twelve months. According to InvestingPro data, the company maintains a GREAT financial health score. Boston Scientific has been noted as one of the few large-cap companies to outperform the S&P this year, with remarkable year-to-date…